NDC 55154-0410

Tradjenta

Linagliptin

Tradjenta is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health 107, Llc. The primary component is Linagliptin.

• Product ID: 55154-0410_1814632c-acfd-4d96-8689-bf35fb6ba900
• NDC: 55154-0410
• Product Type: Human Prescription Drug
• Proprietary Name: Tradjenta
• Generic Name: Linagliptin
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2011-05-09
• Marketing Category: NDA / NDA
• Application Number: NDA201280
• Labeler Name: Cardinal Health 107, LLC
• Substance Name: LINAGLIPTIN
• Active Ingredient Strength: 5 mg/1
• Pharm Classes: Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 55154-0410-8

2640 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0410-8)

• Marketing Start Date: 2011-05-09
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55154-0410-8 [55154041008]

Tradjenta TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA201280
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2011-05-09

Drug Details

Active Ingredients

Ingredient	Strength
LINAGLIPTIN	5 mg/1

OpenFDA Data

• SPL SET ID: dfe327e8-f6ab-41e5-bdef-d520118cd83a
• Manufacturer:
  • Cardinal Health
• UNII:
  • 3X29ZEJ4R2
• RxNorm Concept Unique ID - RxCUI:
  • 1100706
  • 1100702
• UPC Code:
  • 0355154041080

Pharmacological Class

• Dipeptidyl Peptidase 4 Inhibitors [MoA]
• Dipeptidyl Peptidase 4 Inhibitor [EPC]

NDC Crossover Matching brand name "Tradjenta" or generic name "Linagliptin"

NDC	Brand Name	Generic Name
0597-0140	Tradjenta	linagliptin
50090-4383	Tradjenta	linagliptin
55154-0410	Tradjenta	linagliptin